× Thank you for visiting OnlineJACC.org. You have been selected to participate in a brief customer satisfaction survey to let us know how we can improve your experience. The survey is designed to measure your entire experience, please look for it…
Welcome to JACC Edge, a monthly newsletter highlighting hot topics published across the family of JACC Journals. Your browser does not support the audio
Copyright © 2024, American College of Cardiology Foundation. Published by Elsevier Published online November 29,
AbstractBackgroundData on the prognostic role of the TRI-SCORE in patients undergoing transcatheter tricuspid valve intervention (TTVI) are limited.ObjectivesThe aim of this study was to evaluate…
AbstractBackgroundThe natural history of moderate/severe atrial functional mitral regurgitation (AFMR) is unknown.ObjectivesThe authors sought to study the incidence of left ventricular (LV) systol…
AbstractSodium-glucose cotransporter-2 inhibitors (SGLT2is) have been shown to reduce adverse cardiovascular events in patients with type 2 diabetes mellitus, all-cause mortality, and heart failure…
Emory University School of Medicine, Atlanta, Georgia, USA ∗Address for correspondence: Dr Oreoluwa E. Olakunle, Emory University School of Medicine, 100 Woodruff Circle, Atlanta, Georgia…
AbstractBackgroundThe natural history of moderate/severe atrial functional mitral regurgitation (AFMR) is unknown.ObjectivesThe authors sought to study the incidence of left ventricular (LV) systol…
Welcome to JACC Edge, a monthly newsletter highlighting hot topics published across the family of JACC Journals. Your browser does not support the audio
AbstractBackgroundDepression is a known risk factor for cardiovascular disease (CVD), but the potential sex differences in this association remain unclear.ObjectivesThe aim of this study was…
JACC: CardioOncology Editor-in-chief, Bo nnie Ky, MD, MSCE, FACC and David Austin, MD, FRCP discuss PROACT, a phase three randomized open label blinded endpoint superiority…
